Janux Therapeutics (NASDAQ:JANX) Posts Earnings Results, Misses Expectations By $0.18 EPS

Janux Therapeutics (NASDAQ:JANX – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.33) by ($0.18), Briefing.com reports. Janux Therapeutics had a negative net margin of 291.17% and a negative return on equity of 8.78%. The company had revenue […]

Leave a Reply

Your email address will not be published.

Previous post Head to Head Comparison: JBDI Holdings Limited Ordinary Shares (NASDAQ:JBDI) vs. Greif (NYSE:GEF)
Next post Deseret Mutual Benefit Administrators Boosts Holdings in Abbott Laboratories (NYSE:ABT)